한글목차

세계의 MMR 백신 시장 전망은 병원 및 의료기관, 백신 센터 및 공중보건 클리닉, 소아과 및 민간 의료 클리닉의 기회로 인해 유망한 것으로 전망되고 있습니다. 세계 MMR 백신 시장은 2025-2031년 연평균 8.3%의 성장률을 보일 것으로 예측됩니다. 이 시장의 주요 촉진요인은 대부분의 국가에서 MMR 백신이 소아기 정기 접종 일정에 포함되어 있다는 점, 해외 여행으로 인한 국경 간 집단 이동이 증가하고 있다는 점, 백신의 안전성과 대중 교육에 초점을 맞추고 있다는 점입니다.

• Lucintel의 예측에 따르면, 유형별로는 단일가 백신은 예측 기간 동안 높은 성장세를 보일 것으로 예측됩니다.
• 용도별로는 병원 및 의료기관이 높은 성장세를 보일 것으로 예측됩니다.
• 지역별로는 아시아태평양이 예측 기간 동안 가장 높은 성장을 보일 것으로 예측됩니다.

MMR 백신 시장의 새로운 트렌드

세계 MMR 백신 시장은 진화하는 공중보건 수요, 기술 발전, 사회적 요인에 대응하는 새로운 트렌드의 출현으로 큰 변화의 시기를 맞이하고 있습니다. 이러한 추세는 백신 유통을 재구성하고, 접근성을 개선하고, 백신 접종에 대한 주저와 가격 등의 문제를 해결함으로써 전 세계적으로 보다 효과적이고 광범위한 예방접종 프로그램을 보장하고 있습니다.

• 백신 의무화 및 규제 강화: 세계 각국 정부는 MMR 백신 접종을 의무화하고 있으며, 취학 및 여행 시 예방접종을 의무화하고 있습니다. 이러한 추세는 특히 선진국에서 백신 접종률을 크게 끌어올리고 있습니다. 발병을 예방하고 집단 면역을 확보하기 위해서는 보다 강력한 규제 프레임워크와 시행 정책이 필수적입니다.
• 백신 안전성 및 대중 교육에 대한 강조: 공중보건 당국은 표적화된 교육 캠페인을 통해 백신에 대한 잘못된 정보와 접종에 대한 주저를 없애기 위한 노력을 강화하고 있습니다. 백신의 안전성에 대한 우려가 높은 지역도 있기 때문에 높은 접종률을 유지하기 위해서는 투명성, 과학적 소통, 지역사회와의 소통을 더욱 중요시하는 것이 필수적입니다.
• 예방접종 프로그램의 세계 확대: MMR 백신 접종 프로그램을 중저소득 국가, 특히 아프리카와 아시아로 확대하려는 움직임이 활발해지고 있습니다. 국제기구와 각국 정부는 예방접종 서비스를 받지 못하는 지역에서 백신 접종을 확대하고 예방 가능한 질병의 부담을 전 세계적으로 줄이기 위해 협력하고 있습니다.
• 혼합백신 및 개량형 백신: 백신 개발자들은 수두(수두)와 같은 다른 소아 백신에 MMR을 추가한 혼합백신을 개발하기 위해 노력하고 있습니다. 이러한 혼합 백신은 보호자에게 더 편리하고, 예방접종 순응도를 높이고, 의료비용을 절감할 수 있습니다.
• 백신 전달 기술의 발전: 무침주사 시스템, 마이크로니들 패치 등 새로운 백신 전달 기술이 MMR 백신 시장에 보급되고 있습니다. 이러한 기술 혁신은 백신의 수용성을 향상시키고, 주사에 대한 통증과 두려움을 감소시키며, 접근하기 어려운 지역에서의 백신 접종 캠페인을 간소화할 수 있을 것으로 기대됩니다.

이러한 새로운 트렌드는 백신 접종을 개선하고, 접근성을 확대하며, 백신 접종에 대한 거부감을 해소함으로써 MMR 백신의 상황을 변화시키고 있습니다. 각국 정부, 의료 서비스 제공업체 및 제조업체가 질병 예방 문제를 해결하기 위해 협력하는 가운데, 이러한 추세는 전 세계 예방접종 활동을 강화하고 전 세계 홍역, 유행성이하선염 및 풍진 발생률을 감소시킬 것으로 예측됩니다.

MMR 백신 시장의 최근 동향

세계 MMR 백신 시장은 사회적 인식 개선, 백신 기술 발전, 규제 프레임워크의 진화 등을 배경으로 지난 몇 년 동안 몇 가지 중요한 추세를 보이고 있습니다. 이러한 발전은 홍역, 유행성 이하선염, 풍진과 같은 예방 가능한 질병을 퇴치하기 위한 노력에 있어 과제와 기회를 모두 반영하고 있으며, 특히 최근 유행 추세와 백신 접종에 대한 망설임에 직면해 있습니다.

• 백신 의무화 및 규제 강화: 독일과 미국을 포함한 많은 국가에서 취학 전 MMR 백신 접종을 의무화하는 등 보다 엄격한 백신 접종 요건을 시행하고 있습니다. 이러한 규제 변경은 특히 고위험 지역에서 더 많은 어린이들이 백신 접종을 받을 수 있도록 함으로써 전염병 발생을 억제하고 더 높은 접종률을 달성하는 것을 목표로 하고 있습니다.
• 저소득 국가에서의 세계 예방접종 캠페인: WHO와 GAVI를 포함한 세계보건기구(WHO)와 세계보건기구(GAVI)는 의료 서비스를 받지 못하는 지역에 MMR 백신을 제공하기 위한 노력을 강화하고 있습니다. 여기에는 인도와 아프리카 일부 지역과 같은 국가에서 대규모 예방접종 캠페인이 포함되며, 홍역과 풍진 발생률을 낮추기 위해 예방접종률이 낮은 지역에 초점을 맞추었습니다.
• 백신 유통의 기술적 개선: 백신의 보관, 운송, 배송 방법의 발전으로 오지나 농촌 지역에서도 MMR 백신을 쉽게 접할 수 있게 되었습니다. 여기에는 저자원 환경에서 콜드체인 유지와 운송 중 백신의 무결성을 보장하는 데 필수적인 태양열 냉장고, 디지털 추적 시스템 등의 기술 혁신이 포함됩니다.
• 접종률 향상을 위한 혼합백신: MMRV(홍역, 볼거리, 풍진, 수두) 백신과 같은 혼합백신의 도입이 가속화되고 있습니다. 이러한 백신은 특히 유아의 경우, 보다 효율적인 접종 스케줄을 가능하게 하고, 주사 횟수를 줄여 백신 접종 프로그램에 대한 순응도를 높일 수 있습니다.
• 백신 접종 거부감을 해소하기 위한 공중보건 캠페인: 정부와 공중보건 기관은 백신 오보와 싸우고 MMR 백신에 대한 대중의 신뢰를 높이기 위해 대중 교육 및 커뮤니케이션에 주력하고 있습니다. 백신 접종의 안전성과 중요성에 대한 인식을 높이기 위한 캠페인은 예방접종률을 높이고 발병을 예방하는 데 매우 중요합니다.

MMR 백신 시장의 최근 동향은 백신 접근성, 기술 혁신, 규제 강화에 있어 큰 진전을 보이고 있습니다. 각국 정부와 국제기구가 백신 접종에 대한 노력을 강화하는 가운데, 이러한 발전은 전 세계 예방접종률을 높이고 예방 가능한 질병의 부담을 줄이는 데 중요한 역할을 할 것으로 기대됩니다.

목차

제1장 주요 요약

제2장 시장 개요

• 배경과 분류
• 공급망

제3장 시장 동향과 예측 분석

• 거시경제 동향과 예측
• 업계 촉진요인과 과제
• PESTLE 분석
• 특허 분석
• 규제 환경

제4장 세계의 MMR 백신 시장 : 유형별

• 개요
• 매력 분석 : 유형별
• 1가 백신 : 동향과 예측(2019-2031)
• 3가 백신: 동향과 예측(2019-2031년)
• 4가 백신 : 동향과 예측(2019-2031년)

제5장 세계의 MMR 백신 시장 : 유통 채널별

• 개요
• 매력 분석 : 유통 채널별
• 병원 및 의료기관 : 동향과 예측(2019-2031년)
• 백신 센터 및 공중위생 클리닉 : 동향과 예측(2019-2031년)
• 소아과 및 민간 의료 클리닉 : 동향과 예측(2019-2031년)

제6장 지역 분석

• 개요
• 세계의 MMR 백신 시장 : 지역별

제7장 북미의 MMR 백신 시장

• 개요
• 북미의 MMR 백신 시장 : 유형별
• 북미의 MMR 백신 시장 : 유통 채널별
• 미국의 MMR 백신 시장
• 멕시코의 MMR 백신 시장
• 캐나다의 MMR 백신 시장

제8장 유럽의 MMR 백신 시장

• 개요
• 유럽의 MMR 백신 시장 : 유형별
• 유럽의 MMR 백신 시장 : 유통 채널별
• 독일의 MMR 백신 시장
• 프랑스의 MMR 백신 시장
• 스페인의 MMR 백신 시장
• 이탈리아의 MMR 백신 시장
• 영국의 MMR 백신 시장

제9장 아시아태평양의 MMR 백신 시장

• 개요
• 아시아태평양의 MMR 백신 시장 : 유형별
• 아시아태평양의 MMR 백신 시장 : 유통 채널별
• 일본의 MMR 백신 시장
• 인도의 MMR 백신 시장
• 중국의 MMR 백신 시장
• 한국의 MMR 백신 시장
• 인도네시아의 MMR 백신 시장

제10장 기타 지역(ROW)의 MMR 백신 시장

• 개요
• 북미의 MMR 백신 시장 : 유형별
• 북미의 MMR 백신 시장 : 유통 채널별
• 중동의 MMR 백신 시장
• 남미의 MMR 백신 시장
• 아프리카의 MMR 백신 시장

제11장 경쟁 분석

• 제품 포트폴리오 분석
• 운영 통합
• Porter의 Five Forces 분석
  • 경쟁 기업간 경쟁 관계
  • 바이어의 교섭력
  • 공급업체의 교섭력
  • 대체품의 위협
  • 신규 진출업체의 위협
• 시장 점유율 분석

제12장 기회와 전략 분석

• 밸류체인 분석
• 성장 기회 분석
  • 성장 기회 : 유형별
  • 성장 기회 : 유통 채널별
• 세계 MMR 백신 시장의 새로운 동향
• 전략 분석
  • 신제품 개발
  • 인증 및 라이선싱
  • 인수합병(M&A), 계약, 제휴 및 합작투자(JV)

제13장 밸류체인 주요 기업 개요

• Competitive Analysis
• Merck & Co.
• GlaxoSmithKline plc
• Pfizer Inc.
• Novartis AG
• Biological E. Limited

제14장 부록

• 그림 리스트
• 표 리스트
• 분석 방법
• 면책사항
• 저작권
• 약어와 기술 단위
• Lucintel에 대해
• 문의

영문목차

The future of the global MMR vaccine market looks promising with opportunities in hospitals and healthcare institutions, vaccine centers and public health clinics, and pediatric and private healthcare clinics. The global MMR vaccine market is expected to grow with a CAGR of 8.3% from 2025 to 2031. The major drivers for this market are that the MMR vaccine is included in routine childhood vaccination schedules in most countries, international travel has led to an increase in the movement of populations across borders, and there is a focus on vaccine safety and public education.

• Lucintel forecasts that, within the type category, monovalent is expected to witness higher growth over the forecast period.
• Within the application category, hospitals and healthcare institutions are expected to witness higher growth.
• In terms of region, APAC is expected to witness the highest growth over the forecast period.

Emerging Trends in the MMR Vaccine Market

The global MMR vaccine market is undergoing significant transformations as new trends emerge in response to evolving public health needs, technological advancements, and social factors. These trends are reshaping vaccine distribution, improving accessibility, and addressing challenges like vaccine hesitancy and affordability, ensuring more effective and widespread immunization programs globally.

• Increase in vaccine mandates and legislation: Governments worldwide are strengthening MMR vaccine mandates, requiring immunization for school enrollment and travel. This trend is significantly boosting vaccination rates, especially in developed nations. Stronger regulatory frameworks and enforcement policies are critical to preventing outbreaks and ensuring herd immunity.
• Focus on vaccine safety and public education: Public health authorities are intensifying efforts to combat vaccine misinformation and hesitancy through targeted education campaigns. As concerns over vaccine safety persist in some regions, greater emphasis on transparency, scientific communication, and community engagement is essential to maintaining high vaccination coverage.
• Global expansion of immunization programs: There is a growing effort to extend MMR vaccination programs to low- and middle-income countries, especially in Africa and Asia. International organizations and governments are working together to expand access to vaccines in underserved regions, reducing the burden of preventable diseases globally.
• Combination vaccines and improved formulations: Vaccine developers are working on combination vaccines that include MMR alongside other childhood vaccines like varicella (chickenpox). These combination vaccines are more convenient for parents, increase vaccination adherence, and reduce healthcare costs, which can be particularly beneficial in regions with limited resources.
• Technological advancements in vaccine delivery: New vaccine delivery technologies, such as needle-free injection systems and micro-needle patches, are gaining traction in the MMR vaccine market. These innovations are expected to improve vaccine acceptance, reduce pain or fear of injections, and streamline vaccination campaigns in hard-to-reach areas.

These emerging trends are transforming the MMR vaccine landscape by improving vaccine delivery, expanding access, and addressing vaccine hesitancy. As governments, healthcare providers, and manufacturers collaborate to tackle the challenges of disease prevention, these trends promise to enhance global immunization efforts and reduce the incidence of measles, mumps, and rubella worldwide.

Recent Developments in the MMR Vaccine Market

The global MMR vaccine market has seen several key developments in recent years, driven by increased public awareness, advancements in vaccine technology, and evolving regulatory frameworks. These developments reflect both challenges and opportunities in the effort to combat preventable diseases like measles, mumps, and rubella, particularly in the face of recent outbreaks and growing vaccine hesitancy.

• Stronger vaccine mandates and regulations: Many countries, including Germany and the U.S., have implemented stricter vaccination requirements, such as mandatory MMR vaccines for school enrollment. These regulatory changes are aimed at curbing outbreaks and achieving higher vaccination coverage, ensuring that more children are vaccinated, especially in high-risk regions.
• Global vaccination campaigns in low-income countries: Global health organizations, including the WHO and GAVI, have ramped up efforts to deliver MMR vaccines to underserved regions. This includes large-scale immunization campaigns in countries like India and parts of Africa, focusing on areas with low vaccine coverage to reduce the incidence of measles and rubella.
• Technological improvements in vaccine distribution: Advances in vaccine storage, transportation, and delivery methods are improving MMR vaccine accessibility in remote and rural areas. This includes innovations like solar-powered refrigerators and digital tracking systems, which are essential for maintaining the cold chain in low-resource settings and ensuring the integrity of vaccines during transportation.
• Combination vaccines for improved coverage: The introduction of combination vaccines, such as the MMRV (measles, mumps, rubella, and varicella) vaccine, is gaining momentum. These vaccines allow for more efficient vaccination schedules, particularly for young children, reducing the number of injections required and increasing adherence to vaccination programs.
• Public health campaigns to address vaccine hesitancy: Governments and public health agencies are focusing on public education and communication to combat vaccine misinformation and improve public confidence in MMR vaccines. Campaigns aimed at increasing awareness about the safety and importance of vaccination are critical to boosting coverage rates and preventing outbreaks.

Recent developments in the MMR vaccine market highlight significant progress in vaccine access, technological innovation, and regulatory enforcement. As governments and global organizations strengthen vaccination efforts, these developments are expected to play a crucial role in increasing global immunization rates and reducing the burden of preventable diseases.

Strategic Growth Opportunities in the MMR Vaccine Market

The global MMR vaccine market is poised for growth, driven by opportunities across key applications such as pediatric vaccination, public health campaigns, and international outreach programs. By focusing on these areas, the market can expand its reach and address vaccine gaps in high-risk populations, especially in developing countries and underserved communities.

• Expansion of pediatric immunization programs: As childhood immunization remains a key priority for global health organizations, there is significant growth potential in the pediatric segment. Strengthening national immunization programs and reaching underserved areas will increase vaccine uptake and prevent outbreaks, especially in regions with high birth rates.
• Global vaccination campaigns in developing countries: Significant opportunities exist in expanding MMR vaccine access to low-income and middle-income countries, particularly in Africa and Asia. Organizations like GAVI and UNICEF are working to reduce vaccine inequity, providing funding and logistics support to ensure vaccines reach remote and underserved populations.
• Focus on vaccine safety and public education initiatives: Educational campaigns aimed at raising awareness about the safety and efficacy of the MMR vaccine represent a growth opportunity, especially in regions where vaccine hesitancy is high. Addressing misinformation through targeted campaigns can help increase vaccination rates and improve public confidence in the vaccine.
• Combination vaccines for increased adoption: Combination vaccines that include MMR along with other essential vaccines, such as chickenpox (varicella) and hepatitis B, offer a compelling growth opportunity. These vaccines reduce the number of injections required and improve compliance with vaccination schedules, particularly for young children.
• Strengthening healthcare infrastructure in developing regions: Growth opportunities also lie in improving the healthcare infrastructure, particularly in rural and underserved regions. Expanding access to MMR vaccines through mobile clinics, community health workers, and improved cold chain logistics will help improve vaccination coverage and prevent outbreaks in these areas.

Strategic growth opportunities in the MMR vaccine market are primarily driven by expanding access in developing countries, strengthening pediatric vaccination programs, and addressing vaccine hesitancy. As efforts focus on improving accessibility and education, the market has the potential to significantly reduce the burden of measles, mumps, and rubella worldwide.

MMR Vaccine Market Driver and Challenges

The global MMR vaccine market is influenced by a range of drivers and challenges that affect vaccination rates, accessibility, and public health outcomes. These include technological advancements, economic factors, and regulatory policies, as well as challenges like vaccine hesitancy, logistical hurdles, and disparities in healthcare access.

The factors responsible for driving the MMR vaccine market include:

1. Increased government and public health support: Government mandates, such as vaccination requirements for school enrollment, and support from global health organizations like WHO and UNICEF are strong drivers for the MMR vaccine market. These initiatives help expand vaccine coverage, reduce preventable diseases, and ensure higher immunization rates worldwide.

2. Rising awareness of vaccine-preventable diseases: As measles outbreaks increase in certain regions, there is greater awareness of the importance of MMR vaccination. Public health campaigns are educating communities about the risks of vaccine-preventable diseases, driving higher vaccine adoption rates, particularly in developed nations.

3. Improved vaccine accessibility and distribution: Advances in vaccine delivery systems, including better cold chain logistics and digital tracking, are improving access to MMR vaccines, especially in remote and underserved regions. This is helping ensure that vaccines reach populations at risk of preventable diseases.

4. Introduction of combination vaccines: The development and adoption of combination vaccines, such as MMRV (measles, mumps, rubella, and varicella), are helping increase vaccination coverage by reducing the number of injections needed for children. These vaccines simplify immunization schedules, making it easier for parents to comply with vaccination recommendations.

5. International collaboration and funding: Global organizations like GAVI, UNICEF, and the WHO are providing significant funding and logistical support to ensure vaccines reach populations in developing countries. These collaborations are essential for addressing vaccine inequities and improving global immunization rates.

The challenges in the MMR vaccine market are:

1. Vaccine hesitancy and misinformation: Vaccine hesitancy, fueled by misinformation and distrust in vaccines, remains a significant challenge, particularly in high-income countries. Overcoming this challenge requires targeted public education campaigns and transparent communication to build public confidence in the safety and efficacy of the MMR vaccine.

2. Logistical and infrastructure barriers: In many developing regions, inadequate healthcare infrastructure, poor cold chain management, and limited access to healthcare services hinder the effective distribution and delivery of MMR vaccines. These logistical challenges need to be addressed to ensure vaccines reach rural and hard-to-reach areas.

3. Disparities in vaccine access: Disparities in vaccine access, particularly in low- and middle-income countries, continue to impede progress in achieving global immunization goals. Factors such as poverty, conflict, and weak healthcare systems exacerbate these challenges, highlighting the need for targeted intervention and support to reach underserved populations.

The drivers and challenges shaping the global MMR vaccine market reflect a dynamic interplay of factors that influence vaccine adoption, accessibility, and public health outcomes. While increased government support and improved vaccine delivery systems are driving growth, addressing vaccine hesitancy, logistical barriers, and access disparities remains crucial to achieving universal immunization coverage.

List of MMR Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leveraging integration opportunities across the value chain. With these strategies, MMR vaccine companies cater to increasing demand, ensure competitive effectiveness, develop innovative products and technologies, reduce production costs, and expand their customer base. Some of the MMR vaccine companies profiled in this report include:

• Merck & Co.
• GlaxoSmithKline plc
• Pfizer Inc.
• Novartis AG
• Biological E. Limited

MMR Vaccine Market by Segment

The study includes a forecast for the global MMR vaccine market by type, distribution channel, and region.

MMR Vaccine Market by Type [Value from 2019 to 2031]:

• Monovalent
• Trivalent
• Tetravalent

MMR Vaccine Market by Distribution Channel [Value from 2019 to 2031]:

• Hospitals and Healthcare Institutions
• Vaccine Centers and Public Health Clinics
• Pediatric and Private Healthcare Clinics

MMR Vaccine Market by Region [Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the MMR Vaccine Market

Recent developments in the global MMR vaccine market reflect ongoing efforts to increase vaccination coverage and combat rising cases of preventable diseases. Governments, healthcare providers, and vaccine manufacturers are focusing on expanding access, improving vaccine efficacy, and addressing vaccine hesitancy. In regions like the United States, China, Germany, India, and Japan, key advancements are shaping the future of the MMR vaccine landscape, particularly in light of recent outbreaks.

• United States: In the U.S., the MMR vaccine market has seen robust growth due to increased awareness and government mandates, with widespread vaccination programs in schools. Recent efforts focus on addressing vaccine hesitancy, particularly in certain communities, through targeted public health campaigns. Despite high vaccination coverage, localized outbreaks of measles have highlighted the need for continued vigilance and education around the importance of vaccination, ensuring high immunization rates.
• China: China has significantly improved its vaccination infrastructure and coverage, with the MMR vaccine being a part of its routine immunization program. The government has been working to strengthen vaccine supply chains and expand access in rural areas. Recent efforts focus on addressing concerns over vaccine safety and increasing public trust. Increased government funding for vaccination programs is also helping expand coverage, reducing the risk of outbreaks.
• Germany: Germany has made strides in improving MMR vaccination rates, with a renewed focus on strengthening public health policies. The country recently implemented stricter vaccination requirements, mandating the MMR vaccine for school enrollment to address rising cases of measles. Germany's efforts include educational campaigns to boost public confidence and reduce vaccine hesitancy, particularly in areas with lower vaccination rates. The government's response to recent outbreaks has highlighted the importance of universal vaccination.
• India: In India, MMR vaccine coverage has been increasing as part of the national immunization program. The government is focusing on expanding access to vaccines in rural and underserved areas, where healthcare infrastructure is limited. Additionally, India is tackling vaccine hesitancy through community-based programs and educational initiatives. With its large population and high birth rate, India represents a significant market for MMR vaccines, and the government is actively working to reach the remaining unvaccinated groups.
• Japan: Japan has maintained high MMR vaccination coverage, but concerns over vaccine safety and side effects have led to public hesitancy in certain regions. The government has responded with educational campaigns to address fears and ensure higher vaccination rates. Japan's national immunization program offers MMR vaccines to children, and recent reforms focus on streamlining vaccine delivery to increase accessibility, particularly in remote areas. Public-private partnerships are also strengthening the distribution network.

Features of the Global MMR Vaccine Market

• Market Size Estimates: MMR vaccine market size estimation in terms of value ($B).
• Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
• Segmentation Analysis: MMR vaccine market size by type, distribution channel, and region in terms of value ($B).
• Regional Analysis: MMR vaccine market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.
• Growth Opportunities: Analysis of growth opportunities in different types, distribution channels, and regions for the MMR vaccine market.
• Strategic Analysis: This includes M&A, new product development, and the competitive landscape of the MMR vaccine market.

Analysis of the competitive intensity of the industry based on Porter's Five Forces model.

This report answers the following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the MMR vaccine market by type (monovalent, trivalent, and tetravalent), distribution channel (hospitals and healthcare institutions, vaccine centers and public health clinics, and pediatric and private healthcare clinics), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Market Overview

• 2.1 Background and Classifications
• 2.2 Supply Chain

3. Market Trends & Forecast Analysis

• 3.1 Macroeconomic Trends and Forecasts
• 3.2 Industry Drivers and Challenges
• 3.3 PESTLE Analysis
• 3.4 Patent Analysis
• 3.5 Regulatory Environment

4. Global MMR Vaccine Market by Type

• 4.1 Overview
• 4.2 Attractiveness Analysis by Type
• 4.3 Monovalent: Trends and Forecast (2019-2031)
• 4.4 Trivalent: Trends and Forecast (2019-2031)
• 4.5 Tetravalent: Trends and Forecast (2019-2031)

5. Global MMR Vaccine Market by Distribution Channel

• 5.1 Overview
• 5.2 Attractiveness Analysis by Distribution Channel
• 5.3 Hospitals and Healthcare Institutions: Trends and Forecast (2019-2031)
• 5.4 Vaccine Centers and Public Health Clinics: Trends and Forecast (2019-2031)
• 5.5 Pediatric and Private Healthcare Clinics: Trends and Forecast (2019-2031)

6. Regional Analysis

• 6.1 Overview
• 6.2 Global MMR Vaccine Market by Region

7. North American MMR Vaccine Market

• 7.1 Overview
• 7.2 North American MMR Vaccine Market by Type
• 7.3 North American MMR Vaccine Market by Distribution Channel
• 7.4 United States MMR Vaccine Market
• 7.5 Mexican MMR Vaccine Market
• 7.6 Canadian MMR Vaccine Market

8. European MMR Vaccine Market

• 8.1 Overview
• 8.2 European MMR Vaccine Market by Type
• 8.3 European MMR Vaccine Market by Distribution Channel
• 8.4 German MMR Vaccine Market
• 8.5 French MMR Vaccine Market
• 8.6 Spanish MMR Vaccine Market
• 8.7 Italian MMR Vaccine Market
• 8.8 United Kingdom MMR Vaccine Market

9. APAC MMR Vaccine Market

• 9.1 Overview
• 9.2 APAC MMR Vaccine Market by Type
• 9.3 APAC MMR Vaccine Market by Distribution Channel
• 9.4 Japanese MMR Vaccine Market
• 9.5 Indian MMR Vaccine Market
• 9.6 Chinese MMR Vaccine Market
• 9.7 South Korean MMR Vaccine Market
• 9.8 Indonesian MMR Vaccine Market

10. ROW MMR Vaccine Market

• 10.1 Overview
• 10.2 ROW MMR Vaccine Market by Type
• 10.3 ROW MMR Vaccine Market by Distribution Channel
• 10.4 Middle Eastern MMR Vaccine Market
• 10.5 South American MMR Vaccine Market
• 10.6 African MMR Vaccine Market

11. Competitor Analysis

• 11.1 Product Portfolio Analysis
• 11.2 Operational Integration
• 11.3 Porter's Five Forces Analysis
  • Competitive Rivalry
  • Bargaining Power of Buyers
  • Bargaining Power of Suppliers
  • Threat of Substitutes
  • Threat of New Entrants
• 11.4 Market Share Analysis

12. Opportunities & Strategic Analysis

• 12.1 Value Chain Analysis
• 12.2 Growth Opportunity Analysis
  • 12.2.1 Growth Opportunities by Type
  • 12.2.2 Growth Opportunities by Distribution Channel
• 12.3 Emerging Trends in the Global MMR Vaccine Market
• 12.4 Strategic Analysis
  • 12.4.1 New Product Development
  • 12.4.2 Certification and Licensing
  • 12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

13. Company Profiles of the Leading Players Across the Value Chain

• 13.1 Competitive Analysis
• 13.2 Merck & Co.
  • Company Overview
  • MMR Vaccine Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.3 GlaxoSmithKline plc
  • Company Overview
  • MMR Vaccine Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.4 Pfizer Inc.
  • Company Overview
  • MMR Vaccine Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.5 Novartis AG
  • Company Overview
  • MMR Vaccine Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.6 Biological E. Limited
  • Company Overview
  • MMR Vaccine Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing

14. Appendix

• 14.1 List of Figures
• 14.2 List of Tables
• 14.3 Research Methodology
• 14.4 Disclaimer
• 14.5 Copyright
• 14.6 Abbreviations and Technical Units
• 14.7 About Us
• 14.8 Contact Us